Institutional Investors in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) See US$94m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

Simply Wall StMar 1 07:01 ET

Aldeyra Therapeutics | 10-K: Annual report

SECFeb 28 16:37 ET · Announcements

Aldeyra Therapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Aldeyra TherapeuticsFeb 4 00:00 ET

Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?

Yahoo FinanceJan 20 15:28 ET

Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsDec 16, 2024 08:31 ET · Ratings

Analysts' Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Keros Therapeutics (KROS)

TipRanksDec 16, 2024 07:50 ET · Ratings